Letermovir for cytomegalovirus prophylaxis in high‐risk heart transplant recipients-Reference-Cited by-同舟云学术

Letermovir for cytomegalovirus prophylaxis in high‐risk heart transplant recipients

Published:2022-10-26 Issue:12 Volume:36 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clinical Transplantation

Author:

Golob Stephanie¹,Batra Jaya¹,DeFilippis Ersilia M.¹,Uriel Matan¹,Carey Matt¹,Gaine Maureen¹,Mabasa Angelo¹,Fried Justin¹,Raikelkar Jayant¹,Restaino Susan¹,Hi Lee Sun¹,Latif Farhana¹,Yuzefpolskaya Melana¹,Colombo Paolo C.¹,Choe Jason¹,Majure David²,Jennings Douglas¹,Pereira Marcus R.³,Clerkin Kevin¹,Sayer Gabriel¹,Uriel Nir¹

Affiliation:

1. Division of Cardiology Department of Medicine Columbia University College of Physicians and Surgeons New York New York USA

2. Division of Cardiology Department of Medicine Cornell University Ithaca New York USA

3. Division of Infectious Disease Department of Medicine Columbia University College of Physicians and Surgeons New York New York USA

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14808

Reference16 articles.

1. CMV: Prevention, Diagnosis and Therapy